Is Terns Pharmaceuticals Inc (TERN) a Winner in the Biotechnology Industry?

Terns Pharmaceuticals Inc (TERN) is near the middle in its industry group according to InvestorsObserver. TERN gets an overall rating of 54. That means it scores higher than 54 percent of stocks. Terns Pharmaceuticals Inc gets a 48 rank in the Biotechnology industry. Biotechnology is number 17 out of 148 industries.

TERN has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on TERN!

See Full TERN Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 54 would rank higher than 54 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Terns Pharmaceuticals Inc Stock Today?

Terns Pharmaceuticals Inc (TERN) stock is unmoved 0% while the S&P 500 has risen 0.52% as of 1:30 PM on Wednesday, Sep 14. TERN is flat $0.00 from the previous closing price of $6.35 on volume of 351,063 shares. Over the past year the S&P 500 is lower by -11.03% while TERN is down -42.43%. TERN lost -$2.13 per share the over the last 12 months. Click Here to get the full Stock Report for Terns Pharmaceuticals Inc stock.